Promising combo for inflammatory breast cancer stalls after single patient
NCT ID NCT05198843
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested a combination of two drugs—icosapent ethyl (an omega-3 fatty acid) and dasatinib (a targeted cancer drug)—in people with a rare, aggressive form of breast cancer that had spread. The goal was to find a safe dose and see if the combo could shrink tumors. However, the study was stopped early after only one person enrolled, so we have no useful information about whether the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- icosapent ethyl (an omega-3 fatty acid) and dasatinib (a targeted cancer drug)
- What this could lead to
- If it had worked, this combination might have pointed toward a new treatment option for a very aggressive breast cancer.
- What could go wrong
- The trial was terminated after enrolling only 1 person, so no meaningful conclusions can be drawn. It is too early to know if this combination is safe or effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Engineered immune cells join chemo and antibody to attack Hard-to-Treat breast cancer
- Can couples coping together ease the burden of advanced cancer?
- Blood test could track breast cancer in real time
- Wheat germ supplement studied for immune boost in advanced cancer
- Could red light help breast cancer survivors regrow hair after chemo?